Market Overview

Flu Activity Continues to Rise, Related Prescriptions Up 12% from Last Week; Watch CVS, Walgreen

Share:
Related CVS
Needham Sees A Healthy Risk-Reward For CVS Health
Benzinga's Top Upgrades, Downgrades For November 10, 2017
40 Dividend Stocks Battling Into 2018 (Seeking Alpha)
Related WAG
Where Are People Using Apple Pay?
Early Global News: Record Online Sales, 400% Jump In Tinder Users, China Experiences Worst Drop In Months

Lazard Capital Market's Tom Galluci issued an update on flu activity Monday morning following a note from December 17th which suggested CVS (NYSE: CVS) and Walgreen (NYSE: WAG) could benefit from increased cases of the virus.

The analyst said flu activity was up 12 percent from last week and up a very concerning 94 percent from the same week last year. Prescriptions for cold, cough and/or flu drugs has surged 61 percent from December 2011.

Galluci believes this increase in activity is likely to have a greater effect on hospital volume metrics rather than earnings as a lower-margin business.

Lazard maintains a Buy rating on CVS and a Neutral rating on Walgreen shares.

Latest Ratings for CVS

DateFirmActionFromTo
Nov 2017CitigroupMaintainsNeutral
Nov 2017NeedhamUpgradesHoldBuy
Nov 2017Loop CapitalMaintainsHold

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: Analyst Color Analyst Ratings

 

Related Articles (CVS + RAD)

View Comments and Join the Discussion!

Partner Center